Scaling CNS Therapeutics: Rethinking Diagnosis, Delivery & Reimbursement in the Future of a Fragmented System
Time: 12:00 pm
day: Conference Day Two
Details:
- Why underdiagnosis, long wait times, and neurologist shortages restrict access and how CNS therapeutics include the reliance on costly measurement devices (e.g. MRI / PET scans) and the lack of access to such devices at many clinical sites
- What a scalable CNS care model must include: new clinical networks, broader education efforts, and the crucial role of non-profits and patient advocacy groups
